InsidersTradesSigma
Track the Natures Sunshine Products INC stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Natures Sunshine Products INC has recorded 264 public disclosures. Market capitalisation: €257.8m. The latest transaction was filed on 19 August 2026 (Acquisition). Among the most active insiders: Norman Daniel C. All data is openly available.
264
Insider Decl.
n/a
Thresholds
€2m
20 ops.
Buy Volume
€30m
20 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Natures Sunshine Products INC Strong Buy (bullish), based on 2 analysts. Average price target: US$30.50.
40Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,058 of 28,958 companies
76.7
score / 100
Value83
Quality70
FCF yld11%
Earn yld7.8%
EV/EBITDA6.2x
ROE11%
Gross mgn72%
Net mgn4.1%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 August 2026
Declarations264 total
20,000 shares@ US$14.69Common Stock, no par valueSEC:0001166152-26-000011:0
Canonical exit: 15 Nov 2026 (T+90)
1,000 shares@ US$16.480.0057% mcap0.7% of flowCommon Stock, no par valueSEC:0001166152-26-000010:3
Canonical exit: 5 Nov 2026 (T+90)
20,000 shares@ US$16.690.12% mcap14.4% of flowCommon Stock, no par valueSEC:0001166152-26-000010:7
Canonical exit: 5 Nov 2026 (T+90)
10,000 shares@ US$16.720.058% mcap7.2% of flowCommon Stock, no par valueSEC:0001166152-26-000010:8
Canonical exit: 5 Nov 2026 (T+90)
876 shares@ US$15.640.0048% mcap0.6% of flowCommon Stock, no par valueSEC:0001166152-26-000010:9
Canonical exit: 8 Nov 2026 (T+90)
16,928 shares@ US$15.800.093% mcap11.5% of flowCommon Stock, no par valueSEC:0001166152-26-000010:10
Canonical exit: 8 Nov 2026 (T+90)
13,072 shares@ US$15.780.072% mcap8.9% of flowCommon Stock, no par valueSEC:0001166152-26-000010:11
Canonical exit: 8 Nov 2026 (T+90)
10,000 shares@ US$16.010.056% mcap6.9% of flowCommon Stock, no par valueSEC:0001166152-26-000010:12
Canonical exit: 8 Nov 2026 (T+90)
2,000 shares@ US$16.350.011% mcap1.4% of flowCommon Stock, no par valueSEC:0001166152-26-000010:0
Canonical exit: 4 Nov 2026 (T+90)
2,513 shares@ US$16.750.015% mcap1.8% of flowCommon Stock, no par valueSEC:0001166152-26-000010:1
Canonical exit: 4 Nov 2026 (T+90)
10,000 shares@ US$16.460.057% mcap7.1% of flowCommon Stock, no par valueSEC:0001166152-26-000010:2
Canonical exit: 5 Nov 2026 (T+90)
20,000 shares@ US$16.550.12% mcap14.3% of flowCommon Stock, no par valueSEC:0001166152-26-000010:4
Canonical exit: 5 Nov 2026 (T+90)
5,000 shares@ US$16.620.029% mcap3.6% of flowCommon Stock, no par valueSEC:0001166152-26-000010:5
Canonical exit: 5 Nov 2026 (T+90)
30,000 shares@ US$16.680.17% mcap21.6% of flowCommon Stock, no par valueSEC:0001166152-26-000010:6
Canonical exit: 5 Nov 2026 (T+90)
1,976 sharesCommon SharesSEC:0001628280-26-045913:0
12,015 shares@ US$21.840.059% mcap32.0% of flowCommon SharesSEC:0001628280-26-037603:0
3,512 shares@ US$27.070.024% mcap12.7% of flowCommon SharesSEC:0001628280-26-026367:0
951 shares@ US$27.070.0066% mcap9.0% of flowCommon SharesSEC:0001628280-26-026365:0
1,289 shares@ US$27.070.0077% mcap4.2% of flowCommon SharesSEC:0001628280-26-026369:0
1,567 shares@ US$27.070.011% mcap6.2% of flowCommon SharesSEC:0001628280-26-026361:0
1,567 shares@ US$27.070.011% mcap7.5% of flowCommon SharesSEC:0001628280-26-026363:0
11,798 sharesCommon SharesSEC:0001628280-26-021359:0
7,965 sharesCommon SharesSEC:0001628280-26-021377:0
8,180 sharesCommon SharesSEC:0001628280-26-021375:0
29,928 sharesCommon SharesSEC:0001628280-26-021372:0
25 of 264 declarations
About Natures Sunshine Products INC
Nature’s Sunshine Products, Inc. (Nasdaq: NATR) is a United States-listed company trading on the NASDAQ market in the United States. Headquartered in Lehi, Utah, the company is a long-established player in the natural health and wellness space, with a history spanning more than 50 years. Its core business is the formulation, manufacturing and marketing of herbal supplements, nutritional products and selected personal care items, with a brand identity centered on natural ingredients, product quality and wellness-oriented routines. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0000275053/000162828026016535/natrq42025earningsrelease.htm)) From an industry perspective, Nature’s Sunshine sits in the competitive mid-cap consumer health niche where brand trust, ingredient sourcing, regulatory discipline and product innovation are critical. The company emphasizes that it manufactures most of its products through its own facilities, giving it tighter control over quality, safety and efficacy. It also distributes in more than 40 countries worldwide, which provides meaningful geographic diversification and reduces reliance on any single market. That international footprint is particularly relevant for investors looking at a US-based wellness business with a global reach. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0000275053/000162828026016535/natrq42025earningsrelease.htm)) The product portfolio includes herbal and nutritional supplements, everyday wellness formulas, and category-specific lines aimed at digestion, vitality, metabolic support and general health maintenance. In 2025, Nature’s Sunshine relaunched its Power Line with a new Power Balance supplement, signaling active portfolio management and a willingness to refresh its offering around consumer health trends. The company also introduced its first integrated brand platform, “Be More Earth,” which reinforces its natural positioning and underscores the role of ingredient authenticity in its marketing strategy. ([ir.naturessunshine.com](https://ir.naturessunshine.com/news-events/press-releases/detail/260/natures-sunshine-relaunches-revolutionary-power-line-to)) Recent developments point to a more constructive operating backdrop. Through late 2025 and early 2026, the company reported stronger financial performance, lifted guidance, and highlighted improving sales momentum and margin trends. It also continued repurchasing shares while maintaining a solid balance sheet profile, including cash and no debt at year-end 2025 according to its financial communications. For investors, NATR can be viewed as a US natural-health consumer company with international distribution, in-house manufacturing capabilities and a recent operational recovery that may improve its investment case if execution remains consistent. ([ir.naturessunshine.com](https://ir.naturessunshine.com/news-events/press-releases/detail/267/natures-sunshine-reports-strong-fourth-quarter-and-full/?utm_source=openai))
